Conference · London, United Kingdom
The Commercialisation and Application of Enzymes in Biotechnology
Pharmaceuticals · Biochemistry
Key numbers
- Editions on record
- 1first in 2014
About The Commercialisation and Application of Enzymes in Biotechnology
Benchmark your enzyme development and scale-up programmes against proven strategies taken by Pfizer, Dr Reddy’s and Genecor.
Optimise enzyme application and ensure successful product developmentand scale up.
Meet the growing demand for cheaper and sustainability chemistry with practical advice from GSK, Merck and BASF.
Advance enzyme operational stability and immobilisation to reaction conditions with advice from Exeter’s Biocatalysis Centre.
Futureproof your business with latest research into new and emerging enzymes.
Bridge the gap between chemists, biochemists and biologics to accelerate and improve enzyme development - insight from Prof Andreas Liese.
Network, partner and collaborate with key biocatalysis decision-makers from the pharma, fine chemicals, agrow, bioploymer and personal care industry, academia and key chemical suppliers.
Speakers Include
Dr Pat O’Neill, Principal Research Fellow, Process Development Centre, Pfizer, Ireland
Dr Epsen Kvale, COO, Aqua Bio Technology ASA, Norway
David Estell Research Fellow Chemical R&D Genecor
Professor Andreas Kuenkel Vice President, Research Biopolymers BASF, Germany
and many more...
From our listing of this edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2014 | 19–20 Mar 2014 | Charing Cross Hotel London, United Kingdom | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.
Questions
When is The Commercialisation and Application of Enzymes in Biotechnology?
The next dates haven't been confirmed. The last edition we have on record was 19–20 Mar 2014.
Where is it held?
The last edition we have was at Charing Cross Hotel, London, United Kingdom.